NIFTY 50 23351 ▲ (0.03%)
NIFTY NEXT 50 64794.05 ▼ (0.48%)
NIFTY 100 24032.95 ▼ (0.07%)
NIFTY MIDCAP 100 54944.75 ▼ (0.29%)
NIFTY SMALLCAP 100 17871.85 ▲ (0.04%)
NIFTY SMALLCAP 250 16857.3 ▲ (0.09%)
NIFTY MIDCAP SELECT 12279.4 ▼ (0.62%)
NIFTY TOTAL MARKET 12298.95 ▼ (0.05%)
NIFTY BANK 49217.45 ▼ (0.27%)
SENSEX 76882.63 ▼ (0.25%)
BSE BANKEX 55818.16 ▼ (0.39%)

Choksi Laboratories : Q4 2024 Financial Quarterly Report : YoY Sales Up 14.71 %, QoQ Up 26.44 %

Image is loading

Highlights

  • Sales over the Year and quarter: The company experienced a substantial growth of 14.71 % in the past year, substantial increase in net sales/revenue by 26.44 %.
  • Income over the Year and quarter: There has been decline in other income over the past year which is -40 %, Marginal decrease of % in other income during this quarter.
  • Profit over the Year and quarter: Challenges in sustaining profitability for Choksi Laboratories Ltd.. Profit dropped by -77.13 % Year to Year, Choksi Laboratories Ltd.’s profitability increased by 1001.61 % in this quarter.
  • EPS over the Year and quarter: EPS declined by -77.16 % Year to Year. EPS increased by 988.89 % in previous quarter. Positive impact on shareholders.

The comprehensive analytics outlining the performance and outlook of Choksi Laboratories Ltd.”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 9.694 Cr Rs. 8.795 Cr Rs. 11.12 Cr + 26.44 % + 14.71 %
Expenses Rs. 6.31 Cr Rs. 6.56 Cr Rs. 7.64 Cr + 16.46 % + 21.08 %
Operating Profit Rs. 3.38 Cr Rs. 2.24 Cr Rs. 3.48 Cr + 55.36 % + 2.96 %
OPM % 34.87 % 25.47 % 31.29 % + 5.82 % -3.58 %
Other Income Rs. 0.1 Cr Rs. 0 Cr Rs. 0.06 Cr 0 % -40 %
Interest Rs. 0.94 Cr Rs. 0.67 Cr Rs. 0.77 Cr + 14.93 % -18.09 %
Depreciation Rs. 1.43 Cr Rs. 1.43 Cr Rs. 1.49 Cr + 4.2 % + 4.2 %
Profit before tax Rs. 1.11 Cr Rs. 0.14 Cr Rs. 1.28 Cr + 814.29 % + 15.32 %
Tax % 11.42 % 57.53 % 46.93 % -10.6 % + 35.51 %
Net Profit Rs. 2.99 Cr Rs. 0.06 Cr Rs. 0.68 Cr + 1033.33 % -77.26 %
EPS in Rs Rs. 4.29 Rs. 0.09 Rs. 0.98 + 988.89 % -77.16 %


Today, we’re looking at Choksi Laboratories Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 14.71 %. However, it did see a marginal increase of 26.44 % from the previous quarter. Expenses ticked up slightly by 16.46 % quarter-on-quarter, aligning with the annual rise of 21.08 %. Operating profit, while up 2.96 % compared to last year, faced a quarter-on-quarter increase of 55.36 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -3.58 %, but an expansion of 5.82 % sequentially. despite an annual decline of -40 %. Interest expenses surged remarkably by 14.93 % from the previous quarter, yet the year-over-year decrease remains at a moderate -18.09 %. Depreciation costs climbed by 4.2 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 4.2 %. Profit before tax grew annually by 15.32 % but saw an increase from the preceding quarter by 814.29 %.
Tax expenses as a percentage of profits increased slightly by 35.51 % compared to last year, with a more notable quarter-on-quarter decrease of -10.6 %. Net profit fell by -77.26 % year-on-year but experienced a 1033.33 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -77.16 % but a quarterly rise of 988.89 %. In summary, Choksi Laboratories Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 9.694 Cr Rs. 8.795 Cr Rs. 11.12 Cr + 26.44 % + 14.71 %
Expenses Rs. 6.31 Cr Rs. 6.56 Cr Rs. 7.64 Cr + 16.46 % + 21.08 %
Operating Profit Rs. 3.38 Cr Rs. 2.24 Cr Rs. 3.48 Cr + 55.36 % + 2.96 %
Net Profit Rs. 2.99 Cr Rs. 0.06 Cr Rs. 0.68 Cr + 1033.33 % -77.26 %
EPS in Rs Rs. 4.29 Rs. 0.09 Rs. 0.98 + 988.89 % -77.16 %


In reviewing Choksi Laboratories Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 14.71 % year-on-year growth, however, there was a minor increase of 26.44 % from the previous quarter. Expenses rose by 21.08 % compared to the previous year, with a 16.46 % increase quarter-on-quarter. Operating Profit surged by 2.96 % annually, and saw a 55.36 % increase from the last quarter.
Net Profit showed yearly decrease of -77.26 %, and experienced a 1033.33 % increase from the previous quarter. Earnings Per Share (EPS) fell by -77.16 % annually, however rose by 988.89 % compared to the last quarter. In essence, while Choksi Laboratories Ltd. faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”Choksi Laboratories “]

Related Post